Term Sheet

The latest on private equity, M&A, deals and movements — from Wall Street to Silicon Valley

Deals of the day: Major Domo funding

February 6, 2014: 11:00 AM ET

To get deals in your inbox each morning, sign up for our Term Sheet newsletter

Venture Capital Deals

Domo, a Lindon, Utah-based provider of a SaaS executive management platform, has raised $125 million in Series C funding at an $825 million pre-money valuation. TPG Growth led the round, and was joined by Dragoneer Investment Group, Fidelity Investments, Morgan Stanley Investment Management, salesforce.com, T. Rowe, Viking Global Investors and return backers GGV Capital, Greylock Partners, IVP and Mercato Partners. Allen & Co. managed the process. http://www.domo.com

FoodPanda, a European food delivery service, and its Brazilian affiliate (HelloFood) have raised $20 million in new VC funding from firms like Phenomen Ventures. The company was incubated by Rocket Internet, and previously raised more than $20 million from Investment AB, Kinnevik and Penomen. http://www.foodpanda.com

Apartment List, a San Francisco-based apartment search engine, has raised $6 million in new VC funding led by Glynn Capital and Passport Capitalwww.apartmentlist.com

Apportable, a San Francisco-based mobile app and game development company that lets developers share the same code for iOS and Android, has raised $5 million in new VC funding. Backers include Paul Buchheit, Jerry Yang and Alexis Ohanian. www.apportable.com

Docurated, a New York-based document management platform that transforms file storage solutions (Dropbox, SharePoint, etc.) into searchable content, has raised $3.75 million in Series A funding.Rogers Venture Partners led the round. www.docurated.com

FarFaria, a San Francisco-based provider of digital children's books for the iPad, has raised $3.25 million in Series A funding led by Inventus Capital Partnerswww.farfaria.com

Jack Erwin, a New York-based maker of men's shoes, has raised $2 million in Series A funding.Crosslink Capital led the round, and was joined by Shasta Ventures and Menlo Ventures.www.jackerwin.com

Jaguar Animal Health Inc., a San Francisco-based developer of veterinary medicines derived from plants used traditionally in rain forest areas, has held a $2 million first close on its Series A funding round led by BioVeda China Fund. The company had seed seeded by Napo Pharmaceuticals, and has exclusive worldwide license from Napo for all animal rights to products developed from Croton lechleri. www.jaguaranimalhealth.com

DataMentors LLC, a Wesley Chapel, Fla.-based provider of data quality and database marketing solutions, has raised an undisclosed amount of new VC funding. Brook Venture Partners led the round, and was joined by Bay Capital and Pride's Crossing Capital. www.datamentors.com

Genability Inc., a San Francisco-based software company that licenses out its database of electricity tariffs and rate engine for use with third-party products, has raised an undisclosed amount of Series A funding led by EnerNOC Inc. (Nasdaq: ENOC). www.genability.com

Private Equity Deals

AssuredPartners, a Lake Mary, Fla.-based insurance company acquisition platform, has acquiredAirSure Limited LLC, a Golden Colo.-based provider of insurance coverage, employee benefits and risk management services for businesses in the aviation industry. No financial terms were disclosed. AssuredPartners is a portfolio company of GTCRwww.assuredptr.com

Battenfeld Technologies, a Columbia, Mo.-based maker of shooting supplies, has acquiredBOGgear, a Fredericksburg, Texas-based maker of shooting sticks and related accessories for use in hunting, photography and videography. No financial terms were disclosed. Battenfeld is a portfolio company of Clearview Capitalwww.battenfeldtechnologies.com

Envision Pharma Group, a UK-based tech and scientific communication company, has acquiredProScribe, an Australia-based medical writing company. No financial terms were disclosed. Envision Pharma is a portfolio company of The Halifax Groupwww.envisionpharmagroup.com

Huntsman Gay Global Capital has acquired Buy4Now Technology Group, a Dublin, Ireland-based provider of ecommerce software to grocery and retail clients in Europe. No financial terms were disclosed. Buy4Now will become a subsidiary of existing HGGC portfolio company MyWebGrocer Inc. www.buy4now.com

Quadrant Software, a Mansfield, Mass.–based provider of document output management solutions, has acquired a pair of IBM i modernization software companies: Business Computer Design Inc.(Chicago) and ExcelSystems Software Development Inc. (British Columbia). No financial terms were disclosed. Quadrant Software backers include Candescent PartnersBrooke Private Equityand Eagle Private Capitalwww.quadrantsoftware.com

IPO's

Auspex Pharmaceuticals Inc., a La Jolla, Calif.-based developer of treatments for hyperkinetic movement disorders like Huntington's disease, raised $84 million in its IPO. The company priced 7 million shares at $12 per share, compared to earlier plans to offer 5.5 million shares at between $10 and $12 per share. It has an initial market cap of approximately $270 million, and will trade on the Nasdaq under ticker symbol ASPX. Stifel and BMO Capital Markets served as lead underwriters. Shareholders include Thomas, McNerney & Partners (34.6% pre-IPO stake), CMEA Capital (25.8%), Panorama Capital (15.7%) and Deerfield Management (8.3%). www.auspexpharma.com

Biocept Inc., a San Diego-based cancer diagnostics company, raised $19 million in its IPO. The company priced 1.9 million shares at $10 per share (low end of $10-$12 range), and will trade on the Nasdaq under ticker symbol BIOC. Aegis Capital Corp. served as lead underwriter. The company has raised VC funding from such firms as Goodman Medical Ireland, SMC Corp. and Needham Capital Partners. www.biocept.com

Egalet Corp., a Malvern, Penn.-based abuse-deterrent oral products for the treatment of pain and other indications, raised around $50 million in its IPO. The company priced 4.2 million shares at $12 per share, compared to earlier plans to offer 3.5 million shares at between $11 and $13. It has an initial market cap of approximately $167 million, and will trade on Nasdaq under ticker symbol EGLT. Stifel and JMP Securities servedas lead underwriters. Shareholders include Atlas Ventures (30.1% pre-IPO stake), Danish Biotech (22.7%), Sunstone Capital (19.7%), Index Ventures (17.1%) and Enso Ventures (6.2%). www.egalet.com

Genocea Biosciences, a Cambridge, Mass.-based developer of T-cell vaccines for infectious diseases, raised $66 million in its IPO. The company priced 5.5 million shares at $12 per share (low end of $12-$14 range), for an initial market cap of approximately $207 million. It will trade on the Nasdaq under ticker symbol GNCA, while Citigroup and Cowen & Co. served as co-lead underwriters. Genocea had raised over $88 million in VC funding from Polaris Venture Partners (16.3% pre-IPO stake), Lux Ventures (14.8%), S.R. One Ltd. (13%), Johnson & Johnson Development Corp. (11.7%), CVF LLC (9.3%), Skyline Ventures (8.8%), Cycad Group (6.6%), Auriga Ventures (6.5%), The Bill & Melinda Gates Foundation (6.2%) and Morningside Ventures.www.genocea.com

Revance Therapeutics Inc., a Newark, Calif.-based developer of a platform technology that enables local, targeted delivery of large macromolecules across skin (i.e., non-injectable Botox), raised $96 million in its IPO. The company priced 6 million shares at $16 per share, compared to plans to offer 5 million shares at between $14 and $16 per share. It has an initial market cap of approximately $284 million. The company will trade on the Nasdaq under ticker symbol RVNC, while Cowen & Co. and Piper Jaffray served as lead underwriters. Shareholders include Essex Woodlands Health Ventures (36.2% pre-IPO stake), NovaQuest Capital (24.9%), Technology Partners (7.6%), Vivo Ventures (7%), Shepherd Ventures, Palo Alto Investors, Pac-Link Ventures and Essex Capital Corp.www.revance.com

UniQure Inc., a Dutch developer of gene-based therapeutics, raised $92 million in its IPO. The company priced 5.4 million shares at $17 per share (above $13-$15 range), for an initial market cap of approximately $286 million. It will trade on the Nasdaq under ticker symbol QURE, while Jefferies and Leerink Partners served as lead underwriters. The company reports around a €20 million net loss on €2 million in revenue for the first nine months of 2013. Shareholders include Coller Capital (44.5% pre-IPO stake), Forbion (35.6%), Gilde Healthcare (13.5%), Chiesi Farmaceutici (9.1%) and Advent Venture Partners (6.2%). www.uniqure.com

OTHER DEALS

Actuate (Nasdaq: BIRT) has acquired Legodo AG, a German developer of software for rapid generation of personalized customer correspondence. No financial terms were disclosed.www.actuate.com

Coca-Cola (NYSE: KO) has agreed to acquire a 10% stake in Green Mountain Coffee Roasters(Nasdaq: GMCR), for approximately $1.25 billion. The 16.7 million shares are being purchased at $74.98 a piece, which is the volume-weighted average price over the last 50 days. www.gmcr.com

TakeLessons, a San Diego-based online marketplace that connects students will instructors, has acquired Chicago-based online lesson facilitator Betterfly. No financial terms were disclosed. TakeLessons has raised over $10 million in VC funding from Crosslink Capital, SoftTechVC, Webb Investment Network, Triangle Peak Partners and Siemer Ventures. Betterfly was backed by Lightbank. http://www.takelessons.com

Sign up for Dan Primack's daily email newsletter on deals and deal-makers: GetTermSheet.com

Join the Conversation
About This Author
Dan Primack
Dan Primack
Senior Editor, Fortune

Dan Primack joined Fortune.com in September 2010 to cover deals and dealmakers, from Wall Street to Sand Hill Road. Previously, Dan was an editor-at-large with Thomson Reuters, where he launched both peHUB.com and the peHUB Wire email service. In a past journalistic life, Dan ran a community paper in Roxbury, Massachusetts. He currently lives just outside of Boston.

Email a Tip | @danprimack | RSS
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe
Powered by WordPress.com VIP.